Archive - FemmeHealth Ventures Alliance

Alliance Spotlight — Dr. Maria Fay

This month we welcome Dr.

5 hrs ago •

Longevity Misses the Mark: Why Menopause Is the Blind Spot in Aging Science

Women live longer but age worse. Why capital markets and medicine still ignore the biology behind midlife risk.

Jul 13 •

Why Erectile Dysfunction Gets Funded and Women’s Health Gets Dismissed

Capital follows what it values. When investors call women’s health “CSR,” they reveal a billion-dollar blind spot.

Jul 10 •

Even Venus Wasn’t Believed: The Hidden Cost of Delayed Diagnosis in Women’s Health

Why fibroids, funding, and disbelief go hand-in-hand and what investors are still missing.

Jul 6 •

Biotech or Branding? How to Spot Real Science in Women’s Health

Most investors can’t tell a Phase 2 therapeutic from a wellness product with a good story. Here’s how to decode the science and the stakes.

Jul 3 •

June 2025

The Market They Said Didn’t Exist And Why I Built Anyway

They told me women’s health wasn’t worth investing in. I couldn’t let that be the end of the story.

Jun 29 •

Fake Science in Femtech: 3 Ways to Spot Red Flags Before You Buy

Too many startups use the language of science without its rigor. Here’s how to separate evidence-based innovation from marketing dressed as medicine.

Jun 26 •

Since relaunching in January 2025, FemmeHealth Ventures Alliance has grown into a trusted force in women’s health investing that is spotlighting the…

Jun 22 •

The Hidden Reason Promising Women’s Health Startups Fail

What one case taught me about market readiness, investor blind spots, and when mission isn’t enough.

Jun 22 •

The Trillion-Dollar AI Correction

How a viral post on women's health bias spotlighted an overlooked challenge in healthcare data infrastructure

Jun 19 •

What Investors Still Cannot See And Where the Alpha Is Hiding

This week’s dispatch includes the book I wish I’d had at the start plus five new signals shaping the future of women’s health investing.

Jun 15 •

The Book I Wish I’d Had: A Strategic Guide to Investing in Women’s Health Innovation

Why the smartest capital often misses the most lucrative healthcare opportunities and how investors can find alpha in women’s health, diagnostics, and…

Jun 15 •

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts